GDNF-Induced Expression of Tyrosine Hydroxylase

  • K. Kiuchi
  • H. Xiao
Part of the Advances in Behavioral Biology book series (ABBI, volume 53)


Glial cell line-derived neurotrophic factor (GDNF) was first identified as a protein with specific neurotrophic activity affecting the dopaminergic neurons of the substantia nigra.1 Since then, several studies have shown that GDNF plays an important role in mediating the survival of dopaminergic neurons.2, 3 The signal transduction pathway through which GDNF exerts this effect is thought to be GFRα-1 and Ret-dependent,4 and to involve MAP kinase and PI-3 kinase.5, 6 The tyrosine hydroxylase (TH) gene is considered to be a likely target for GDNF signaling, since intrastriatal injection of GDNF enhances nigral TH activity and dopamine content (in postnatal rats10). First discovered by Nagatsu et al. in 1964,7 TH catalyzes the rate-limiting step in catecholamine biosynthesis and since then has been the subject of numerous studies investigating the regulation of its expression and activity.8,9 The principle processes controlling the number and intrinsic catalytic activity of this enzyme include: (i) modulation of its transcription; (ii) modulation of its translation; (iii) mRNA splicing, (iv) modulation of mRNA stability; (v) phosphorylation; and (vi) feedback inhibition. Here we investigate in more detail the relationship between GDNF stimulation and TH expression.


Tyrosine Hydroxylase Dopaminergic Neuron Human Neuroblastoma Cell Tyrosine Hydroxylase Gene Intrastriatal Injection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    L.F. Lin, D.H. Doherty, J.D. Lile, S. Bektesh, and F. Collins, GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons, Science 260, 1130–1132 (1993).PubMedCrossRefGoogle Scholar
  2. 2.
    D.M. Gash, Z. Zhang, A. Ovadia, W.A. Cass, A. Yi, L. Simmerman, D. Russell, D. Martin, P.A. Lapchak, F. Collins, B J. Hoffer, and G.A. Gerhardt, Functional recovery in parkinsonian monkeys treated with GDNF, Nature 380, 252–255 (1996).PubMedCrossRefGoogle Scholar
  3. 3.
    C. Winkler, H. Sauer, C.S. Lee, and A. Bjorklund, Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson’s disease, J. Neurosci. 16, 7206–7215 (1996).PubMedGoogle Scholar
  4. 4.
    S. Jing, D. Wen, Y. Yu, P.L. Holst, Y. Luo, M. Fang, R. Tamir, L. Antonio, Z. Hu, R. Cupples, J.C. Louis, S. Hu, B.W. Altrock, and G.M. Fox, GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF, Cell 85, 1113–1124 (1996).PubMedCrossRefGoogle Scholar
  5. 5.
    C.A. Worby, Q.C. Vega, Y. Zhao, H.H. Chao, A.F. Seasholtz, and J.E. Dixon, Glial cell line-derived neurotrophic factor signals through the RET receptor and activates mitogen-activated protein kinase. J. Biol. Chem. 271, 23619–23622 (1996).PubMedCrossRefGoogle Scholar
  6. 6.
    H. Hayashi, M. Ichihara, T. Iwashita, H. Murakami, Y. Shimono, K. Kawai, K. Kurokawa, Y. Murakumo, T. Imai, H. Funahashi, A. Nakao, and M. Takahashi, Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor, Oncogene 19, 4469–4475 (2000).PubMedCrossRefGoogle Scholar
  7. 7.
    T. Nagatsu, M. Levitt, and S. Udenfriend, Tyrosine hydroxylase: the initial step in norepinephrine biosynthesis, J. Biol. Chem. 239, 2910–2917 (1964).PubMedGoogle Scholar
  8. 8.
    S.C Kumer, and K.E. Vrana, Intricate regulation of tyrosine hydroxylase activity and gene expression, J. Neurochem. 67, 443–462 (1996).PubMedCrossRefGoogle Scholar
  9. 9.
    T. Nagatsu, and L. Stjarne, Catecholamine synthesis and release, Adv Pharmacol. 42, 1–14 (1998).PubMedCrossRefGoogle Scholar
  10. 10.
    K.D. Beck, I. Irwin, J. Valverde, T.J. Brennan, J.W. Langston, and F. Hefti, GDNF induces a dystonia-like state in neonatal rats and stimulates dopamine and serotonin synthesis, Neuron 16, 665–673 (1996).PubMedCrossRefGoogle Scholar
  11. 11.
    I. Flceda, Y. Ishizaka, T. Tahira, T. Suzuki, M. Onda, T. Sugimura, and M. Nagao, Specific expression of the ret proto-oncogene in human neuroblastoma cell lines, Oncogene 5, 1291–1296 (1990).Google Scholar
  12. 12.
    M. Trupp, R. Scott, S.R. Whittemore, and C.F. Ibanez, Ret-dependent and -independent mechanisms of glial cell line-derived neurotrophic factor signaling in neuronal cells, J. Biol. Chem. 274, 20885–20894 (1999).PubMedCrossRefGoogle Scholar
  13. 13.
    K. Miyazaki, N. Asai, T. Iwashita, M. Taniguchi, T. Isomura, H. Funahashi, H. Takagi, M. Matsuyama, and M. Takahashi, Tyrosine kinase activity of the ret proto-oncogene products in vitro, Biochem Biophys Res Commun. 193, 565–570 (1993).PubMedCrossRefGoogle Scholar
  14. 14.
    M.F. Czyzyk-Krzeska, and J.E. Beresh, Characterization of the hypoxia-inducible protein binding site within the pyrimidine-rich tract in the 3’-untranslated region of the tyrosine hydroxylase mRNA, J. Biol. Chem. 271, 3293–3299 (1996).PubMedCrossRefGoogle Scholar
  15. 15.
    M. Holcik, and S.A. Liebhaber, Four highly stable eukaryotic mRNAs assemble 3’ untranslated region RNA-protein complexes sharing cis and trans components, Proc. Natl. Acad. Sci. USA 94, 2410–2414 (1997).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • K. Kiuchi
    • 1
    • 2
  • H. Xiao
    • 1
  1. 1.Laboratory for Genes of Motor SystemsBio-Mimetic Control Research Center, RIKENNagoyaJapan
  2. 2.Department of Biomolecular Science, Faculty of EngineeringGifu UniversityGifuJapan

Personalised recommendations